Trial Profile
Prospective, Randomized Trial of Belatacept Switch in Renal Transplant Recipients With Delayed Graft Function
Status:
Discontinued
Phase of Trial:
Phase 0
Latest Information Update: 27 Sep 2021
Price :
$35
*
At a glance
- Drugs Belatacept (Primary) ; Everolimus
- Indications Delayed graft function
- Focus Therapeutic Use
- 17 Sep 2021 Status changed from recruiting to discontinued.
- 23 Jan 2017 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017.
- 23 Jan 2017 Planned primary completion date changed from 1 Sep 2016 to 1 Dec 2017.